Dear Editor
Reading the recent editorial by Ghoniem and Rizk [1] was enjoyable, as it highlights the current resurrection of the autologous fascial sling procedure in the surgical treatment of stress urinary incontinence in women. The authors have correctly cited the conclusion of the systematic review by Fusco et al. [2] , suggesting that, with regard to objective cure rates, synthetic slings might have been superior to Burch colposuspension. I would like to draw the authors' attention to a recent letter and reply [3] that questioned such a conclusion, particularly as the relevant Cochrane review [4] had concluded that there was no significant difference in the objective outcomes between synthetic slings and colposuspension.
The cited systematic review [2] had included a trial of Blaparoscopic^colposuspension among the Bopenĝ roup and had applied meta-analysis to a secondary, rather than the primary, outcome of the Ward and Hilton study [5] , the main RCT in the open group. Outcome switching could have been the reason behind a conclusion that is in variance with the Cochrane Review. When meta-analysis was applied solely to the primary outcomes of all relevant and correctly placed RCTs, the conclusion reached by the Cochrane Review was that the objective outcome of the colposuspension procedure is not significantly different from that of synthetic slings (mid-urethral mesh tapes). Therefore, the authors' description of the renaissance may apply to colposuspension and to the autologous pubovaginal sling.
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